NOCIL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.5 INR | -1.09% |
|
-5.25% | -4.04% |
| Feb. 08 | Transcript : NOCIL Limited, Q3 2024 Earnings Call, Feb 08, 2024 | |
| 2023 | Transcript : NOCIL Limited, Q2 2024 Earnings Call, Nov 03, 2023 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 34.54 and 27.63 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -4.04% | 525M | C | ||
| +2.56% | 102B | A- | ||
| -1.92% | 66.01B | A- | ||
| +47.62% | 41.76B | B | ||
| +15.99% | 38.66B | B | ||
| +4.25% | 32.28B | A- | ||
| +8.78% | 19.57B | B- | ||
| +12.32% | 16.77B | C+ | ||
| +17.69% | 15.08B | B- | ||
| +8.31% | 14.83B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NOCIL Stock
- Ratings NOCIL Limited
